American Association for Cancer Research

SHERPA: Unknown

People

  1. Schultz
    Schultz
  2. Patil
    Patil
  3. Berger
    Berger
  4. Solit
    Solit
  5. Hudis
    Hudis
  6. Panageas
    Panageas
  7. Gonen
    Gonen
  8. Scher
    Scher
  9. Heller
    Heller
  10. Ladanyi
    Ladanyi

Groups

  1. Epidemiology and Biostatistics (521)
  2. Department of Medicine (346)
  3. Biostatistics Service (329)
  4. Solid Tumor Oncology Division (316)
  5. GSK Faculty (299)
  6. Population Sciences Research Program (215)
  7. Department of Pathology and Laboratory Medicine (198)
  8. Human Oncology and Pathogenesis Program (195)
  9. Surgery (178)
  10. Survivorship Research (170)
Search Within
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (282)
  2. Meeting Abstract (237)
  3. Correspondence (1)
  4. Editorial (1)
Groups
  1. Epidemiology and Biostatistics (521)
  2. Department of Medicine (346)
  3. Biostatistics Service (329)
  4. Solid Tumor Oncology Division (316)
  5. GSK Faculty (299)
  6. Population Sciences Research Program (215)

More Groups

People
  1. Nikolaus Schultz (90)
  2. Sujata Patil (69)
  3. Michael Berger (66)
  4. David Solit (58)
  5. Clifford Hudis (55)
  6. Larry Norton (48)

More People

Years
  1. 2025 (2)
  2. 2024 (16)
  3. 2023 (14)
  4. 2022 (52)
  5. 2021 (37)
  6. 2020 (48)

More Years

Publications
  1. Cancer Research (274)
  2. Clinical Cancer Research (247)

Results (521)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Analysis of shared variants between cancer biospecimens
    Journal Article

    Foote, M. B.; White, J. R.; Chatila, W. K.; Argilés, G.; Lu, S.; Rousseau, B.; Artz, O.; Johannet, P.; Walch, H.; Patel, M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma
    Journal Article

    Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Phase 2 trial of regorafenib in recurrent/metastatic adenoid cystic carcinoma
    Journal Article

    Desilets, A.; Vos, J. L.; Katabi, N.; Kuo, F.; Nadeem, Z.; Linxweiler, M.; Ostrovnaya, I.; Baxi, S.; Dunn, L. A.; Sherman, E. J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase II study assessing long-term response to ibrutinib monotherapy in recurrent or refractory CNS lymphoma
    Journal Article

    Grommes, C.; Nandakumar, S.; Schaff, L. R.; Gavrilovic, I.; Kaley, T. J.; Nolan, C. P.; Stone, J.; Thomas, A. A.; Tang, S. S.; Wolfe, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Multiplexed spatial profiling of Hodgkin Reed–Sternberg cell neighborhoods in classic Hodgkin lymphoma
    Journal Article

    Pourmaleki, M.; Jones, C. J.; Mellinghoff, S. D.; Greenstein, B. D.; Kumar, P.; Foronda, M.; Navarrete, D. A.; Campos, C.; Roshal, M.; Schultz, N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A novel approach to quantify heterogeneity of intrahepatic cholangiocarcinoma: The hidden-genome classifier
    Journal Article

    Song, Y.; Boerner, T.; Drill, E.; Shin, P.; Kumar, S.; Sigel, C.; Cercek, A.; Kemeny, N.; Abou-Alfa, G.; Iacobuzio-Donahue, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: